Crosslink Therapeutics Inc. Undisclosed stage: $5.5M

Oct 20, 2026Verified by OSH — Confirmed by at least two independent sources or a primary document (filing, official announcement).

Crosslink Therapeutics Inc. raised $5.5 million in an undisclosed stage round, announced Oct. 20.

Facts

Company: Crosslink Therapeutics Inc.
Amount: $5.5 million
Currency: USD
Stage: Undisclosed stage
Announced: Oct 20, 2026
Instrument: Equity

Filing

Form D · filed Oct 20, 2026

Sources

1.Form D: Crosslink Therapeutics Inc. — SEC EDGAR, Oct 20, 2026 · Filing

Verified by OSH — Confirmed by at least two independent sources or a primary document (filing, official announcement).Last verified Oct 21, 2026